Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients.

Kidney international - 1 Jan 2002

Stefoni Sergio, Cianciolo Giuseppe, Donati Gabriele, Dormi Ada, Silvestri Maria Grazia, Colì Luigi, De Pascalis Antonio, Iannelli Sandra

Abstract excerpt

BACKGROUND: It is thought that transforming growth factor-beta1 (TGF-beta1) might be a key inhibitor of atherogenesis in non-uremic patients. We evaluated the intra- and post-dialytic serum levels of TGF-beta1 in uremic patients to assess if TGF-beta1 is an independent risk factor for cardiovascular diseases, and if any correlation exists between TGF-beta1 and any yet known atherosclerotic risk factors. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Artery Disease
Share to Kidney Failure, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myocardial Ischemia

Share to Renal Dialysis

Share to Survival Analysis

Share to Transforming Growth Factor beta

Share to Transforming Growth Factor beta1

Share to Uremia

Source

Identifiers

PMID: 11786115
DOI: 10.1046/j.1523-1755.2002.00119.x

Genes

CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients.PMID 11786115Read ↗

TGF-β <sub>1</sub> DNA Polymorphisms, Protein Levels, and Blood PressureSemantic proximity Read ↗

Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients.Semantic proximity Read ↗

TGF-β and atherosclerosis in manSemantic proximity Read ↗

Association of TGF-beta1 polymorphisms with chronic renal disease.Semantic proximity Read ↗

Telomere attrition is associated with inflammation, low fetuin‐A levels and high mortality in prevalent haemodialysis patientsSemantic proximity Read ↗

Telomere length, cardiovascular risk and arteriosclerosis in human kidneys: an observational cohort studySemantic proximity Read ↗

The risk of dialysis access thrombosis is related to the transforming growth factor-beta1 production haplotype and is modified by polymorphisms in the plasminogen activator inhibitor-type 1 gene.Semantic proximity Read ↗

Variations in serum transforming growth factor-beta1 levels with gender, age and lifestyle factors of healthy Japanese adults.Semantic proximity Read ↗

Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients.Semantic proximity Read ↗

Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension.Semantic proximity Read ↗

A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis.Semantic proximity Read ↗

Delayed In Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature AtherosclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.